Cancer 24 , 379392 (2017)
Key Takeaway Not all peptide therapy is created equal
There have been postmarketing reports of renal impairment, acute kidney injury, and worsening of chronic renal failure, which sometimes has required hemodialysis, in patients treated with GLP-1 receptor agonists
A lack of B12 may cause damage to the fatty substance known as myelin, that covers your nerves and allows the brain to communicate with other parts of your body
High-pressure microscopy for tracking dynamic properties of molecular machines
However, certain types of synthetic peptides thought to be linked to muscle growth, known as growth hormone secretagogues (GHS), may be illegal and unsafe